SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

ZUCCATO, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.964
AS - Asia 3.582
EU - Europa 2.649
SA - Sud America 623
AF - Africa 79
OC - Oceania 21
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.920
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.830
SG - Singapore 1.364
CN - Cina 1.217
PL - Polonia 597
BR - Brasile 555
IT - Italia 470
DE - Germania 433
UA - Ucraina 335
HK - Hong Kong 305
GB - Regno Unito 209
TR - Turchia 194
VN - Vietnam 149
FI - Finlandia 143
SE - Svezia 115
RU - Federazione Russa 105
ID - Indonesia 80
IN - India 71
CA - Canada 65
FR - Francia 64
MX - Messico 56
NL - Olanda 45
AR - Argentina 36
ZA - Sudafrica 33
BD - Bangladesh 32
JP - Giappone 25
ES - Italia 24
PK - Pakistan 24
BE - Belgio 19
IR - Iran 19
CZ - Repubblica Ceca 18
AU - Australia 15
LT - Lituania 15
AT - Austria 13
IQ - Iraq 13
EC - Ecuador 12
GR - Grecia 12
AE - Emirati Arabi Uniti 11
EG - Egitto 11
MY - Malesia 10
KR - Corea 9
VE - Venezuela 8
MA - Marocco 7
TN - Tunisia 7
CH - Svizzera 6
CO - Colombia 6
LY - Libia 6
NZ - Nuova Zelanda 6
TH - Thailandia 6
AZ - Azerbaigian 5
IL - Israele 5
JO - Giordania 5
KE - Kenya 5
RO - Romania 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
NG - Nigeria 4
PH - Filippine 4
TW - Taiwan 4
BG - Bulgaria 3
CR - Costa Rica 3
DZ - Algeria 3
KZ - Kazakistan 3
YE - Yemen 3
AL - Albania 2
CL - Cile 2
HN - Honduras 2
IE - Irlanda 2
JM - Giamaica 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
RS - Serbia 2
TT - Trinidad e Tobago 2
AO - Angola 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BZ - Belize 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
SI - Slovenia 1
Totale 12.917
Salva come PNG Salva come JPEG
Città #
Singapore 719
Ashburn 608
Warsaw 593
Woodbridge 573
Beijing 472
Chandler 411
Fairfield 407
Jacksonville 381
Santa Clara 336
Houston 310
Hong Kong 304
Ann Arbor 296
Wilmington 182
Seattle 142
Ferrara 136
Nanjing 134
Cambridge 120
New York 118
Munich 117
Izmir 114
Los Angeles 104
Dallas 94
Princeton 91
Bologna 69
Boardman 65
Shanghai 62
Addison 61
Jakarta 59
Bremen 55
Turku 52
Milan 51
Ho Chi Minh City 49
Shenyang 42
Redwood City 41
Hefei 39
San Diego 39
Mexico City 36
São Paulo 34
Hanoi 31
Brooklyn 27
Rio de Janeiro 27
Nanchang 26
Jiaxing 24
London 23
Moscow 23
Tianjin 23
Toronto 23
Dearborn 22
Falkenstein 22
Jinan 22
Changsha 21
Hebei 20
Auburn Hills 19
Brussels 18
Chennai 18
Chicago 18
San Francisco 18
Tokyo 18
Denver 17
Ferrara di Monte Baldo 17
Belo Horizonte 16
Johannesburg 16
Stockholm 16
Atlanta 15
Buffalo 15
Falls Church 15
Brasília 14
Dong Ket 14
Mountain View 14
Phoenix 14
Curitiba 13
Helsinki 13
Leiden 13
Montreal 13
San Jose 13
Boston 12
Brno 12
Guangzhou 12
Poplar 12
Zhengzhou 12
Frankfurt am Main 11
Manchester 11
Norwalk 11
Ningbo 10
Orem 10
Sydney 9
Varese 9
Verona 9
Ankara 8
Fars 8
Indiana 8
Kunming 8
Porto Alegre 8
The Dalles 8
Washington 8
Biên Hòa 7
Buenos Aires 7
Des Moines 7
New Delhi 7
Nuremberg 7
Totale 8.438
Salva come PNG Salva come JPEG
Nome #
An Aγ-globin G->A gene polymorphism associated with β(0)39 thalassemia globin gene and high fetal hemoglobin production 383
A validated cellular biobank for β-thalassemia 359
BCL11A mRNA targeting by miR-210: A possible network regulating γ-globin gene expression 313
TREATMENT OF BETA-THALASSEMIA PATIENTS WITH RAPAMYCIN (SIROLIMUS): FROM PRE-CLINICAL RESERCH TO A CLINICAL TRIAL 312
A validated THALAMOSS cellular biobank for β-thalassemia 287
The (A)gamma(+25 G -> A) polymorphism is associated with high HbF production leading to a decrease in binding activity of the LYAR transcription factor to the (A)gamma-globin gene in beta-thalassemia patients 241
Generation and characterization of a transgenic mouse carrying a functional human β-globin gene with the IVSI-6 thalassemia mutation 238
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 225
A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction 202
Increase of microRNA-210, decrease of raptor gene expression and alteration of mammalian target of rapamycin regulated proteins following mithramycin treatment of human erythroid cells 187
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 185
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 183
Discovery of novel fetal hemoglobin inducers for β-thalassemia by small chemical library screening 175
Structure and Biological Activity of Furocoumarins 174
A Saccharomyces cerevisiae model suitable for screening of correctors of stop-codon mutations 169
Combining gene therapy with fetal hemoglobin induction on erythroid precursor cells from β039 and IVS-I-110 thalassemia patients 163
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 162
The multicenter THALAMOSS cellular Biobank for β-Thalassemia 162
Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia 161
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G>A) polymorphic Aγ-globin gene sequences mutated in β-thalassemia 154
Double effects of mithramycin during induction of fetal hemoglobin: down regulation of BCL11A gene transcription and inhibition of the binding of the BCL11A transcriptional complex to the -globin gene promoter 153
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β(0)-Thalassemia Families with High Fetal Hemoglobin Levels 150
Erythroid Induction of Chronic Myelogenous Leukemia K562 Cells Following Treatment with a Photoproduct Derived from the UV-A Irradiation of 5-Methoxypsoralen 148
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters 148
Differentiation and apoptosis in UVA-irradiated cells treated with furocoumarin derivatives 146
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 145
Cellular biosensors for the identification of fetal hemoglobin inducers 144
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 143
PNAs targeting BCL11A at the miR-210 binding sites down-regulate BCL11A and up-regulate gamma-globin mRNA 142
Encapsulation of mithramycin into polymeric micelles by microfluidics: Regulation of the expression of the human γ-globin genes 141
Erythroid differentiation ability of butyric acid analogues: Identification of basal chemical structures of new inducers of foetal haemoglobin 140
Development and molecular characterization of transgenic mice for beta-thalassemia 138
Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproducts 138
Effects on erythroid differentiation of platinum(II) complexes of synthetic bile acid derivatives 138
Expression of γ-globin genes in β-thalassemia patients treated with sirolimus: results from a pilot clinical trial (Sirthalaclin) 132
Bergamot (Citrus bergamia Risso) fruit extracts as gamma-globin gene expression inducers: Phyto-chemical and functional perspectives 132
Gene therapy combined with HbF induction in beta-thalassemia 130
Involvement of miRNA in erythroid differentiation 129
Resveratrol: Antioxidant activity and induction of fetal hemoglobin in erythroid cells from normal donors and β-thalassemia patients 129
Transcription factors (TFs) negatively regulating gamma-globin gene transcription: BCL11A is down-regulated during mithramycin induction of erythroid cells from beta-thalassemia patients 127
New synthetic isoxazole derivatives as potent inducer of fetal hemoglobin (HbF) in beta-thalassemia 126
Preparation and biological evaluation of some 1,2-O-isopropylidene-D-hexofuranose esters 125
Effects of Tobramycin activity on premature termination codons and interleukin 8 gene expression 125
Targeting the miR-221/miR-222 cluster in cancer therapy 121
Recent trends in the gene therapy of β-thalassemia 120
Gene therapy and fetal hemoglobin induction 116
A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs 115
Production and molecular characterization of transgenic mice models for screening therapeutic agents for beta-thalassemia 113
Induction of erythroid differentiation and increased globin mRNA production with furocoumarins and their photoproducts. 112
Synthesis and cellular pharmacology studies of a series of 2-amino-3-aroyl-4-substituted thiophene derivatives 112
Down-regulation of LYAR is associated with induction of fetal hemoglobin in mithramycin-treated erythroid cells 112
Sirolimus-mediated induction of fetal hemoglobin in beta-thalassemia: impact of the XmnI rs74482144 polymophism 112
Increase of the expression of gamma-globin gene in human erytroid cells treated with psoralens 109
Everolimus is a potent inducer of erythroid differentation and gamma-globin gene expression in human erythroid cells 107
null 107
Hemoglobin production in beta-thalassemia erythroid cells following alteration of biomolecular pathways regulating globin gene expression 106
Production of s-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous s039 thalassemia patients 104
null 103
Effects of rapamycin on accumulation of alpha-, beta- and gamma-globin mRNAs in erythroid precursor cells from beta-thalassaemia patients 102
Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs 102
Evidences for miRNA regulation of BCL11A gene expression 101
Efficient CRISPR-Cas9-based genome editing of β-globin gene on erythroid cells from homozygous β039-thalassemia patients 101
Therapeutic molecules for the development of a read-through approach for diseases caused by nonsense mutations 100
Effects of Sirolimus treatment on patients with β-Thalassemia: Lymphocyte immunophenotype and biological activity of memory CD4+ and CD8+ T cells 98
Readthrough of the premature stop codon beta039-thalassemia 97
Mithramycin-mediated induction of K562 cell erythroid differentiation is associated with inhibition of the mTOR-CI patway 97
Thalassemia mouse model for beta-globin gene IVSI-6 mutation 97
Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus 95
Mithramycin-mediated regulation of raptor gene transcription during erythroid differentiation of K562 cells 94
Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report Study 93
Human bladder carcinoma cell line 5637 encapsulated in alginate microbeads: release of interleukins, chemokines and growth factors. 92
Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression 92
Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β039-Globin Gene Editing and Induction of Fetal Hemoglobin 91
A β-Thalassemia Cell Biobank: Updates, Further Validation in Genetic and Therapeutic Research and Opportunities During (and After) the COVID-19 Pandemic 91
Increase of accumulationof gamma-globin mRNA in human erythroid cells treated with psoralens 91
Generation and molecular characterization of a transgenic mouse line carrying a mutated human β°39 thalassemia β-globin gene 91
Production of a cellular model for the screening of inducers of fetal haemoglobin 89
Inhibitory effects of SARS-CoV-2 spike protein and BNT162b2 vaccine on erythropoietin-induced globin gene expression in erythroid precursor cells from patients with β-thalassemia 88
null 87
null 85
Development of a transgenic mouse line carrying a functional human Beta-globin gene with the IVSI-6 thalassemia mutation for in vivo screening and validation of aberrant splicing correctors 85
Sex-specific transcriptional profiles identified in β-thalassemia patients 83
Induction of accumulation of gamma-globin mRNA in human erythroid cells treated with psoralens 82
Orphan Drugs and Potential Novel Approaches for Therapies of β-Thalassemia: Current Status and Future Expectations 82
Increased Expression of α-Hemoglobin Stabilizing Protein (AHSP) mRNA in Erythroid Precursor Cells Isolated from β-Thalassemia Patients Treated with Sirolimus (Rapamycin) 81
Effects of Mithramycin on BCL11A Gene Expression and on the Interaction of the BCL11A Transcriptional Complex to γ-Globin Gene Promoter Sequences 80
Novel biological activity of psoralens. Induction of accumulation of g-globin mRNA in human erythroid cells 79
Erythroid differentiation induced by mithramycin in K562 cells is associated with inhibition of the mTOR-C1 pathway 77
Induction of accumulation of gamma-globin mRNA in human erythroid cells treated with psoralens 76
Treatment of erythroid precursor cells from β‐thalassemia patients with cinchona alkaloids: Induction of fetal hemoglobin production 75
null 75
THALAssaemia MOdular Stratification System for personalized therapy of beta-thalassemia 74
New Synthetic Isoxazole Derivatives Acting as Potent Inducers of Fetal Hemoglobin in Erythroid Precursor Cells Isolated from β-Thalassemic Patients 72
Teaching during COVID-19 pandemic in practical laboratory classes of applied biochemistry and pharmacology: A validated fast and simple protocol for detection of SARS-CoV-2 Spike sequences 71
The rs368698783 (G>A) Polymorphism Affecting LYAR Binding to the Aγ-Globin Gene Is Associated with High Fetal Hemoglobin (HbF) in β-Thalassemia Erythroid Precursor Cells Treated with HbF Inducers 66
Ultra sensitive plasmonic devices for early cancer diagnosis 65
Production and Characterization of K562 Cellular Clones Hyper-Expressing the Gene Encoding α-Globin: Preliminary Analysis of Biomarkers Associated with Autophagy 62
The Long Scientific Journey of Sirolimus (Rapamycin): From the Soil of Easter Island (Rapa Nui) to Applied Research and Clinical Trials on β-Thalassemia and Other Hemoglobinopathies 57
null 52
Expression of miR-210 during erythroid differentiation and induction of gamma-globin gene expression 51
Totale 12.792
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.156
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 606
Totale 62.762
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021840 0 0 0 0 0 126 58 135 35 155 213 118
2021/2022852 87 77 37 25 50 42 46 37 23 80 85 263
2022/2023958 95 91 23 125 174 129 72 82 81 8 42 36
2023/2024673 34 103 27 17 82 124 78 45 10 8 16 129
2024/20252.395 74 57 201 141 270 189 73 104 387 308 317 274
2025/20263.143 634 285 483 758 900 83 0 0 0 0 0 0
Totale 13.179